RE:RE:Price drops?PUNT senior management and the BOD. Bigger shareholders need to bring in another team since this one is clearly inept at managing shareholder value. They are running a lifestyle company where they earn a big salary and continue to raise money with no regard for shareholders.
These guys would have not lasted in the oil sector. Why are medtech investors are so willing to sponsor such wasteful spending and dilution. The huge mistake was rolling out so many sales reps vs establishing in a few major centres while FDA test work is done. Investor houses are greedy and think they will do well by placing their bets on the most recent dilution but that never seems to work out here do to over promise and under deliver mentality to see their jobs.
Fire these guys and put in place a more competent leadership team. Surely that can be done. These guys do not deserve the reward of seeing this to completion after their incompetence at managing the business and marketing plan.
My two cents ...